Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
25.7 USD | +1.16% | -2.08% | -10.68% |
04:18pm | Labcorp Receives US FDA's Approval for Companion Diagnostic Device for Use With Pfizer's Hemophilia B Gene Therapy | MT |
03:30pm | Pfizer: presents new data at ASCO 2024 | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.68% | 144B | |
+26.02% | 661B | |
+26.69% | 566B | |
-6.65% | 352B | |
+20.39% | 332B | |
+2.51% | 283B | |
+13.49% | 231B | |
+4.80% | 200B | |
-9.28% | 195B | |
-5.39% | 145B |
- Stock Market
- Equities
- PFE Stock
- News Pfizer, Inc.
- Atlantic Equities Adjusts Pfizer's Price Target to $46 From $50, Keeps Neutral Rating